The lung in paracoccidioidomycosis: New insights into old problems

Clinics

Volumn 68, Issue 4, 2013, Pages 441-448

  Costa, Andre Nathan ^a   Benard, Gil ^a   Pereira Albuquerque, Andre Luis ^a   Fujita, Carmem Lucia ^a   Kono Magri, Adriana Satie ^a   Salge, João Marcos ^a   Shikanai Yasuda, Maria Aparecida ^a   Ribeiro Carvalho, Carlos Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Computed tomography; Lung; Paracoccidioidomycosis; Pulmonary function; Quality of life

Indexed keywords

EID: 84878138393     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(04)02     Document Type: Article

References (47)

1. Lutz A. Uma mycose pseudococcidica localisada na boca e observada no Brazil. Contribuicao ao conhecimento das hyphoblastomycoses amer-icanas. Bras Med. 1908;(22):121-124.
2. Funari M, Kavakama J, Shikanai-Yasuda MA, Castro LG, Bernard G, Rocha MS, et al. Chronic pulmonary paracoccidioidomycosis (South American blastomycosis): high-resolution CT findings in 41 patients. AJR Am J Roentgenol. 1999;173(1):59-64.
3. Bethlem EP, Capone D, Maranhao B, Carvalho CR, Wanke B. Paracoccidioidomycosis. Curr Opin Pulm Med. 1999;5(5):319-325, http://dx.doi.org/10.1097/00063198-199909000-00010.
4. Queiroz-Telles F, Escuissato DL. Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med. 2011;32(6):764-774, http://dx.doi.org/10.1055/s-0031-1295724.
5. Blotta MH, Mamoni RL, Oliveira SJ, Nouer SA, Papaiordanou PM, Goveia A, et al. Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg. 1999;61(3):390-394.
6. Coutinho ZF, Silva D, Lazéra M, Petri V, Oliveira RM, Sabroza PC, et al. Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saúde Pública. 2002;18(5):1441-1454, http://dx.doi.org/10.1590/S0102-311X2002000500037.
7. Rodrigues Gda S, Severo CB, Oliveira Fde M, Moreira Jda S, Prolla JC, Severo LC. Association between paracoccidioidomycosis and cancer. J Bras Pneumol. 2010;36(3):356-362.
8. Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. Am J Trop Med Hyg. 2011;85(3):546-550, http://dx.doi.org/10.4269/ajtmh.2011.11-0084.
9. Shikanai-Yasuda MA, Telles Filho Fde Q, Mendes RP, Colombo AL, Moretti ML. [Guidelines in paracoccidioidomycosis]. Rev Soc Bras Med Trop. 2006;39(3):297-310.
10. Shikanai-Yasuda MA, Benard G, Higaki Y, Del Negro GM, Hoo S, Vaccari EH, et al. Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. Med Mycol. 2002;40(4):411-417.
11. Tercarioli GR, Bagagli E, Reis GM, Theodoro RC, Bosco Sde M, Macoris SA, et al. Ecological study of Paracoccidioides brasiliensis in soil: growth ability, conidia production and molecular detection. BMC Microbiol. 2007;7:92, http://dx.doi.org/10.1186/1471-2180-7-92.
12. Restrepo S, Tobon A, Trujillo J, Restrepo A. Development of pulmonary fibrosis in mice during infection with Paracoccidioides brasiliensis conidia. J Med Vet Mycol. 1992;30(3):173-184, http://dx.doi.org/10.1080/02681219280000241.
13. Tuder RM, el Ibrahim R, Godoy CE, De Brito T. Pathology of the human pulmonary paracoccidioidomycosis. Mycopathologia. 1985;92(3):179-188, http://dx.doi.org/10.1007/BF00437631.
14. Lemle A, Wanke B, Miranda JL, Kropf GL, Mandel MB, Mandel S. Pulmonary function in paracoccidioidomycosis (South American blas-tomycosis). An analysis of the obstructive defect. Chest. 1983;83(5):827-828, http://dx.doi.org/10.1378/chest.83.5.827.
15. Tobon AM, Agudelo CA, Osorio ML, Alvarez DL, Arango M, Cano LE, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis. 2003;37(7):898-904, http://dx.doi.org/10.1086/377538.
16. Del Negro GM, Pereira CN, Andrade HF, Palacios SA, Vidal MM, Charbel CE, et al. Evaluation of tests for antibody response in the follow-up of patients with acute and chronic forms of paracoccidioidomycosis. J Med Microbiol. 2000;49(1):37-46.
17. de Camargo ZP. Serology of paracoccidioidomycosis. Mycopathologia. 2008;165(4-5):289-302, http://dx.doi.org/10.1007/s11046-007-9060-5.
18. Souza AS, Gasparetto EL, Davaus T, Escuissato DL, Marchiori E. High-resolution CT findings of 77 patients with untreated pulmonary paracoccidioidomycosis. AJR Am J Roentgenol. 2006;187(5):1248-1252, http://dx.doi.org/10.2214/AJR.05.1065.
19. Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397-406.
20. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999;32(6):703-717.
21. Neder JA, Andreoni S, Peres C, Nery LE. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res. 1999;32(6):729-737, http://dx.doi.org/10.1590/S0100-879X1999000600008.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338, http://dx.doi.org/10.1183/09031936.05.00034805.
23. Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, Sachs A, et al. Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomised study. Eur Respir J. 1999;14(6):1304-1313, http://dx.doi.org/10.1183/09031936.99.14613049.
24. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
25. Soares MR, Pereira CA. Six-minute walk test: reference values for healthy adults in Brazil. J Bras Pneumol. 2011;37(5):576-583.
26. Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J. 2002;19(3):405-413, http://dx.doi.org/10.1183/09031936.02.00213202.
27. Sousa TC, Jardim JRB, Jones PW. Validação do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Bras Pneumol. 2000;16:119-125, http://dx.doi.org/10.1590/S0102-35862000000300004.
28. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586, http://dx.doi.org/10.1136/thx.54.7.581.
29. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34(12):1008-1018.
30. Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, et al. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003;123(5):1401-1417, http://dx.doi.org/10.1378/chest.123.5.1401.
31. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available at: http://www.goldcopd.org/. Accessed 26 April 2012. Journal [serial on the Internet]. Date [cited 2011: Available from: http://www.goldcopd.org/.
32. Lemle A, Wanke B, Mandel MB. Pulmonary localization of paracocci-dioidomycosis: lung function studies before and after treatment. Rev Inst Med Trop Sao Paulo. 1983;25(12):73-78.
33. Afonso JE, Nery LE, Romaldini H, Bogossian M, Ribeiro-Ratto O. [Pulmonary function in paracoccidioidomycosis (South American blastomycosis)]. Rev Inst Med Trop Sao Paulo. 1979;21(6):269-280.
34. Marchiori E, Zanetti G, Escuissato DL, Souza AS, Jr., Meirelles Gde S, Fagundes J, et al. Reversed Halo Sign: High-Resolution CT Scan Findings in 79 Patients. Chest. 2012;141(5):1260-1266, http://dx.doi.org/10.1378/ chest.11-1050.
35. Naranjo TW, Lopera DE, Diaz-Granados LR, Duque JJ, Restrepo AM, Cano LE. Combined itraconazole-pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioido-mycosis in mice. Pulm Pharmacol Ther. 2010;24(1):81-91.
36. Marchiori E, Valiante PM, Mano CM, Zanetti G, Escuissato DL, Souza AS, Jr., et al. Paracoccidioidomycosis: high-resolution computed tomography-pathologic correlation. Eur J Radiol. 2009;77(1):80-84.
37. Barreto MM, Marchiori E, Amorim VB, Zanetti G, Takayassu TC, Escuissato DL, et al. Thoracic Paracoccidioidomycosis: Radiographic and CT Findings. Radiographics. 2012;32(1):71-84, http://dx.doi.org/10.1148/rg.321115052.
38. Lemle A, Vieira LO, Milward GA, Miranda JL. Lung function studies in pulmonary South American blastomycosis. Correlation with clinical and roentgenologic findings. Am J Med. 1970;48(4):434-442.
39. Campos EP, Cataneo AMJ. Função pulmonar na evolução de 35 pacientes com paracoccidioidomicose. Rev Inst Med Trop Sao Paulo. 1986;28(5):330-336, http://dx.doi.org/10.1590/S0036-46651986000500008.
40. Campos EP, Padovani CR, Cataneo AMJ. Paracoccidioidomicose: estudo radiológico e pulmonar de 58 casos. Rev Inst Med Trop Sao Paulo. 1991;33(4):267-276, http://dx.doi.org/10.1590/S0036-46651991000400005.
41. Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest. 2012;141(1):222-231, http://dx.doi.org/10.1378/chest.11-1062.
42. Benard G. An overview of the immunopathology of human paracoccidioi-domycosis. Mycopathologia. 2008;165(4-5):209-221, http://dx.doi.org/10.1007/s11046-007-9065-0.
43. Calich VL, Vaz CA, Burger E. Immunity to Paracoccidioides brasiliensis infection. Res Immunol. 1998;149(4-5):407-417; discussion 99-500, http://dx.doi.org/10.1016/S0923-2494(98)80764-5.
44. Kim WJ, Hoffman E, Reilly J, Hersh C, Demeo D, Washko G, et al. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J. 2011;37(1):39-43, http://dx.doi.org/10.1183/09031936.00173009.
45. Santos WA, Silva BM, Passos ED, Zandonade E, Falqueto A. Associação entre tabagismo e paracoccidioidomicose: um estudo de caso-controle no Estado do Espi{dotless}rito Santo, Brasil. Cad Saúde Pública. 2003;19(1):245-253, http://dx.doi.org/10.1590/S0102-311X2003000100027.
46. Stamm AM, Dismukes WE. Current therapy of pulmonary and disseminated fungal diseases. Chest. 1983;83(6):911-917, http://dx.doi.org/10.1378/chest.83.6.911.
47. Menezes VM, Soares BG, Fontes CJ. Drugs for treating paracoccidioido-mycosis. Cochrane Database Syst Rev. 2006;2:CD004967.